Skip to main content

Table 5 Multivariate-adjusted odds ratio (95% CI) for MetS and its components across quartiles of HLS of 202 men and 145 women, participated in the cross-sectional study, Tabriz, Iran

From: The association between healthy lifestyle score and risk of metabolic syndrome in Iranian adults: a cross-sectional study

Variable

Men

   

P

Women

   

P

Q1(N = 58)

Q2(N = 135)

Q3(N = 109)

Q4(N = 45)

 

Q1(N = 58)

Q2(N = 135)

Q3(N = 109)

Q4(N = 45)

 

MetS

 Crude

1 (Ref.)

1.22 (0.28–1.58)

1.29 (0.31–1.76)

1.18 (0.35–1.56)

0.12

1 (Ref.)

1.39 (0.89–2.74)

1.36 (0.85–2.27)

1.28 (0.84–2.59)

0.33

 Model 1

1 (Ref.)

1.28 (0.27–1.94)

1.21 (0.34–1.98)

1.08 (0.37–1.41)

0.22

1 (Ref.)

1.35 (0.92–2.93)

1.33 (0.84–2.29)

1.29 (0.83–2.09)

0.62

 Model 2

1 (Ref.)

1.29 (0.26–1.96)

1.22 (0.32–1.99)

1.09 (0.36–1.39)

0.15

1 (Ref.)

1.32 (1.03–2.91)

1.31 (0.83–2.78)

1.28 (0.81–2.43)

0.28

High WC

 Crude

1 (Ref.)

0.93 (0.56–1.45)

1.08 (0.68–1.73)

0.83 (0.56–1.35)

0.72

1 (Ref.)

1.04 (0.62–1.65)

0.82 (0.54–1.42)

0.83 (0.54–1.29)

0.68

 Model 1

1 (Ref.)

0.88 (0.57–1.52)

0.98 (0.53–1.66)

0.85 (0.42–1.47)

0.9

1 (Ref.)

0.97 (0.54–1.67)

0.87 (0.49–1.45)

0.82 (0.43–1.34)

0.57

 Model 2

1 (Ref.)

0.86 (0.46–1.54)

0.97 (0.55–1.64)

0.78 (0.43–1.35)

0.85

1 (Ref.)

0.96 (0.45–1.36)

0.69 (0.37–1.26)

0.68 (0.34–1.30)

0.53

High TG

 Crude

1 (Ref.)

1.20 (0.26–1.66)

1.23 (0.26–1.84)

0.25 (0.23–1.69)

0.26

1 (Ref.)

1.25 (0.12–1.85)

1.35 (0.16–1.24)

1.18 (0.20–3.14)

0.08

 Model 1

1 (Ref.)

1.22 (0.25–1.81)

1.16 (0.23–1.77)

0.85 (0.21–1.05)

0.14

1 (Ref.)

1.28 (0.13–1.87)

1.33 (0.15–1.29)

1.19 (0.17–3.24)

0.06

 Model 2

1 (Ref.)

1.24 (0.25–1.93)

1.26 (0.24–1.67)

0.86 (0.22–0.97)

0.03

1 (Ref.)

1.27 (0.10–1.93)

1.32 (0.12–1.37)

1.21 (0.15–3.34)

0.17

Low HDL-C

 Crude

1 (Ref.)

1.76 (0.25–2.29)

0.58 (0.17–1.97)

0.60 (0.10–3.49)

0.38

1 (Ref.)

1.54 (0.19–1.68)

1.02 (0.28–3.67)

0.47 (0.17–1.86)

0.68

 Model 1

1 (Ref.)

1.74 (0.24–2.49)

0.68 (0.18–2.61)

0.81 (0.11–5.64)

0.72

1 (Ref.)

1.41 (0.11–1.69)

0.75(0.14–3.96)

0.22 (0.12–2.15)

0.89

 Model 2

1 (Ref.)

1.63 (0.18–2.17)

0.57 (0.11–2.95)

0.53 (0.05–5.10)

0.5

1 (Ref.)

1.40 (0.10–1.67)

0.77 (0.12–4.73)

0.20 (0.11–2.24)

0.34

Hyperglycemia

 Crude

1 (Ref.)

1.20 (0.16–1.65)

1.19 (0.15–1.73)

1.13 (0.11–1.34)

0.01

1 (Ref.)

0.97 (0.27–2.37)

0.47 (0.08–2.74)

1.20 (0.28–1.19)

0.97

 Model 1

1 (Ref.)

1.23 (0.16–1.84)

1.20 (0.14–1.02)

1.13 (0.12–1.01)

0.01

1 (Ref.)

0.60 (0.12–2.01)

0.38 (0.04–2.40)

1.25 (0.18–1.18)

0.97

 Model 2

1 (Ref.)

1.23 (0.16–1.90)

1.20 (0.12–1.45)

1.14 (0.11–1.28)

0.02

1 (Ref.)

0.91 (0.15–2.29)

0.73 (0.06–2.57)

1.20 (0.24–1.16)

0.48

Elevated blood pressure

 Crude

1 (Ref.)

1.34 (0.10–1.14)

1.37 (0.09–1.45)

1.62 (0.09–4.17)

0.37

1 (Ref.)

1.15 (0.52–1.85)

1.53 (0.75–1.95)

1.83 (0.47–2.35)

0.09

 Model 1

1 (Ref.)

1.27 (0.06–1.13)

1.26 (0.05–1.34)

1.37 (0.04–3.53)

0.21

1 (Ref.)

1.20 (0.44–1.98)

1.26 (0.74–1.61)

1.23 (0.63–2.52)

0.06

 Model 2

1 (Ref.)

1.34 (0.07–1.50)

1.52 (0.07–3.53)

1.90 (0.06–2.12)

0.73

1 (Ref.)

1.37 (0.10–1.20)

1.57 (0.08–1.23)

1.92 (0.05–2.32)

0.43

  1. Abbreviations HDL-C High-density lipoprotein-cholesterol, WC Waist circumference
  2. P-values are reported based on the binary logistic regression test and are considered significant at ˂0.05. Bold Values indicate P < 0.05 as the level of significance. Model 1: Adjusted for age, energy intake. Model 2: Model 1 + occupation status, educational level, marital status, BMI, and physical activity
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us